Professor Lei Fu received his B.Sc. and M. Sc. degrees in Chemistry from Fudan University, Shanghai, China, and his Ph.D. degree in Chemistry from Stanford University under the direction of Dr. James P. Collman. He joined Pharmacyclics Inc. (then acquired by AbbVie), California in 1998 as a scientist and then group leader. He led the drug discovery development, process research on anti-cancer and anti-cardiovascular diseases. He has been a Summer visiting scholar in the Department of Chemistry, Stanford University since 2009, and a scientific consultant to several pharmaceutical companies.Dr. Lei Fu has been a Professor of Medicinal Chemistry at Shanghai Jiao Tong University since March of 2006. The research in his group interfaces chemistry and medicine. His principal interests are 1) drug discovery and development; 2) process research on drug APIs and related substances; 3) traditional Chinese medicines as botanical cosmeceuticals; 4) medical devices as targeted drug delivery systems and 5) human hibernation studies using biomimetic models of cytochrome c oxidase. Dr. Fu teaches undergraduate and graduate courses, including Principles of Medicinal Chemistry, Comprehensive Pharmacy, Presenting Science, Chemistry and Pharmacology for layman etc.Dr. Fu is an adjunct Professor at Roosevelt University and Santa Clara University in the US, also an Editor of Bioorganic Chemistry (Elsevier) and Pharmaceutical Fronts (Thieme).Dr. Fu has over 70 peer-reviewed publications mainly in drug discovery. Several of them were published in Science, PNAS, Chemical Reviews, Angewandte Chemie International Edition, Journal of American Chemical Society, Journal of Medicinal Chemistry, Accounts of Chemical Research, Journal of Organic Chemistry and European Journal of Medicinal Chemistry. He holds more than 20 US and China Patents.Dr. Fu invented two cosmeceutical products containing traditional Chinese medicines (TCMs) and licensed to German companies, Henkel and Beiersdorf, respectively.Dr. Fu initiated a collaborative research project with Ethiopia Addis Ababa University, Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa, supported by the World Bank and State government), on the development of Africa local medicinal herbal and establishment of Africa herbal pharmacopeia.

Human Hibernation Studies using Biomimetic Models of Cytochrome c Oxidase.

Medical Devices as Targeted Drug Delivery Systems

Traditional Chinese Medicines as Botanical Cosmeceuticals

Process Research on Drug APIs and Related Substances

Drug Discovery and Development for Metabolic and Neurodegenerative Diseases

Professor, Executive Dean (2023.09 to present) Academy of Pharmacy, XJTLU

Professor, Associate Dean for Learning and Teaching (2020.12 to 2023.08) Academy of Pharmacy, XJTLU

Associate Dean, Professor of Medicinal Chemistry (2006.3-2020.11)School of Pharmacy ,Shanghai Jiao Tong University

Co-Founder, Director (2005.3-2008.12)ND Pharmaceuticals, Inc. Shanghai, China

Principal Investigator and Group Leader (1998.11-2005.1)Pharmacyclics, Inc. Sunnyvale, California., USA

Postdoctoral Research Associate (1997.3-1998.10)Department of Chemistry ,Stanford University, California

Invited Scientist (1990.9-1993.8)Department of Chemistry ,Free University Berlin, Germany

Lecturer (1987.9-1990.8)Fudan University, Shanghai, China